Stockholm Stock Exchange

Novo Nordisk pivots strategy to counter patent cliff

112 clusters · 548 sources · last updated 2 days ago

Latest: Novo Nordisk faces intense competition in obesity drug market

Novo Nordisk is implementing a strategic reset to address long-term growth concerns and the looming patent expiration of semaglutide in the early 2030s. To diversify its portfolio and counter competition from Eli Lilly,

Stockholm Stock Exchange market volatility

2 clusters · 3 sources · last updated 5 days ago

Latest: Stockholm Stock Exchange declines amid mixed corporate reports

The Stockholm Stock Exchange experienced a period of decline driven by broader European market trends and mixed corporate earnings reports. Initial trading saw the OMXS30 index fall 1.03 percent, with the real estate se